Contact nuupeptide
A correction is easiest to investigate when it arrives with the sentence and the source.
Editorial address
editorial@nuupeptide.com
A page path, the wording in question and a PMID or DOI give a useful starting point. If a finding has been given too much scope, identify the population or outcome that needs closer attention. A broken source link is worth reporting too.
A precise disagreement is welcome here. A note about the heart experiment or the MOTS-c cohort is easier to investigate than a general request to declare a molecule effective.
Clinical correspondence
This mailbox cannot handle treatment requests, product orders or dosing questions. It is not continuously monitored and cannot provide urgent assistance. Clinical questions need a healthcare professional with access to the relevant medical history. For the published studies, the references and NAD+ vs MOTS-c comparison remain available on the site.